NextCure Inc expected to post a loss of 40 cents a share - Earnings Preview

NextCure

28/04/2025 12:34

NextCure Inc NXTC.OQ NXTC.O is expected to show no change in quarterly revenue when it reports  results on April 30 (estimated) for the period ending March 31 2025

​LSEG's mean analyst estimate for NextCure Inc is for a loss of 40 cents per share.

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for NextCure Inc is $3.00​, above​ its last closing price of $0.46. ​​​

This summary was machine generated April 28 at 11:34 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)